Published in Mol Cancer Ther on July 01, 2008
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr Med Chem (2012) 1.34
Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer (2011) 1.07
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors. J Immunother (2011) 1.02
The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis. Front Oncol (2012) 1.01
Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages. Mol Ther Nucleic Acids (2013) 0.94
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.93
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen. J Nucl Med (2015) 0.91
Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis. BMC Cancer (2012) 0.85
The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol (2007) 18.33
Mutations of mitotic checkpoint genes in human cancers. Nature (1998) 11.20
The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol (2006) 10.76
Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell (2003) 9.90
Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol (1975) 8.68
How proteolysis drives the cell cycle. Science (1996) 8.59
The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol Biol Cell (1995) 6.23
Inactivation of hCDC4 can cause chromosomal instability. Nature (2004) 5.71
Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol (1999) 5.62
Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol (2001) 4.90
Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature (2007) 4.31
Visualization of Mad2 dynamics at kinetochores, along spindle fibers, and at spindle poles in living cells. J Cell Biol (2000) 4.26
Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell (1998) 4.21
Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature (2007) 4.14
Centrosome-dependent exit of cytokinesis in animal cells. Science (2001) 3.68
Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex. Mol Biol Cell (2002) 3.65
The spindle checkpoint, aneuploidy, and cancer. Oncogene (2004) 3.61
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res (1999) 3.58
Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J (2003) 3.54
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem (2004) 3.49
Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell (2001) 3.36
Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol (2002) 3.04
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology (1996) 2.77
Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res (1997) 2.72
Clathrin is required for the function of the mitotic spindle. Nature (2005) 2.45
Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res (1998) 2.38
Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proc Natl Acad Sci U S A (2004) 2.19
The reversibility of mitotic exit in vertebrate cells. Nature (2006) 2.16
Genomic instability and colon cancer. Cancer Metastasis Rev (2004) 2.15
The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol (2004) 1.99
Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res (2007) 1.96
Budding yeast Bub2 is localized at spindle pole bodies and activates the mitotic checkpoint via a different pathway from Mad2. J Cell Biol (1999) 1.92
A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen. Mol Biol Cell (2003) 1.60
Regulation of the Bfa1p-Bub2p complex at spindle pole bodies by the cell cycle phosphatase Cdc14p. J Cell Biol (2002) 1.58
Clathrin in mitotic spindles. Am J Physiol Cell Physiol (2000) 1.40
p55CDC/hCDC20 is associated with BUBR1 and may be a downstream target of the spindle checkpoint kinase. Oncogene (2000) 1.39
Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol (2005) 1.31
Functional analysis of the spindle-checkpoint proteins using an in vitro ubiquitination assay. Methods Mol Biol (2004) 1.30
Centrosomes have a role in regulating the destruction of cyclin B in early Drosophila embryos. Curr Biol (2000) 1.26
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen. Semin Oncol (2003) 1.24
HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule. Proc Natl Acad Sci U S A (2004) 1.23
Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res (2003) 1.22
Timing of events in mitosis. Curr Biol (2002) 1.20
Dynamics of the apical plasma membrane recycling system during cell division. Traffic (2003) 1.13
Inhibition of the anaphase-promoting complex by the Xnf7 ubiquitin ligase. J Cell Biol (2005) 1.09
Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int J Cancer (2001) 1.06
Large-scale purification of the vertebrate anaphase-promoting complex/cyclosome. Methods Enzymol (2005) 0.96
N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Mol Cancer Ther (2005) 0.94
Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate (2003) 0.85
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res (2006) 5.90
Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A (2003) 2.96
Identification of a MAD2-binding protein, CMT2, and its role in mitosis. EMBO J (2002) 1.96
Rapid microtubule-independent dynamics of Cdc20 at kinetochores and centrosomes in mammalian cells. J Cell Biol (2002) 1.95
Chemical genetic control of protein levels: selective in vivo targeted degradation. J Am Chem Soc (2004) 1.93
The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell (2005) 1.90
Three-dimensional visualization of gammaherpesvirus life cycle in host cells by electron tomography. Structure (2010) 1.65
A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen. Mol Biol Cell (2003) 1.60
Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol (2009) 1.53
Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J Biol Chem (2006) 1.44
Clinical trials of cancer therapies targeting prostate-specific membrane antigen. Rev Recent Clin Trials (2007) 1.43
CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood (2007) 1.39
Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell (2004) 1.33
Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Mol Genet Metab (2005) 1.31
Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol (2005) 1.31
Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia. Leuk Res (2008) 1.31
Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab Invest (2004) 1.30
Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc Natl Acad Sci U S A (2009) 1.29
Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Cancer Res (2012) 1.22
Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res (2003) 1.22
Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell (2003) 1.22
The role of miRNA in inflammation and autoimmunity. Autoimmun Rev (2013) 1.22
Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells. Am J Physiol Gastrointest Liver Physiol (2006) 1.19
HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma. Cancer (2012) 1.17
Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res (2009) 1.16
Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo. Ophthalmology (2006) 1.16
Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow. Mol Genet Metab (2003) 1.15
Transscleral fine-needle aspiration biopsy of macular choroidal melanoma. Am J Ophthalmol (2007) 1.14
Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther (2010) 1.13
A novel mitochondrial outer membrane protein, MOMA-1, that affects cristae morphology in Caenorhabditis elegans. Mol Biol Cell (2011) 1.12
Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer (2003) 1.10
Na,K-ATPase inhibition alters tight junction structure and permeability in human retinal pigment epithelial cells. Am J Physiol Cell Physiol (2003) 1.09
Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB. Mol Genet Metab (2004) 1.08
Calcium-activated calpain-2 is a mediator of beta cell dysfunction and apoptosis in type 2 diabetes. J Biol Chem (2009) 1.08
Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol (2002) 1.07
Na,K-ATPase and epithelial tight junctions. Front Biosci (Landmark Ed) (2009) 1.07
Interactions of tight junctions with membrane channels and transporters. Biochim Biophys Acta (2007) 1.06
Janus model of the Na,K-ATPase beta-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization. J Mol Biol (2006) 1.05
Clear cell renal cell carcinoma: multiphasic multidetector CT imaging features help predict genetic karyotypes. Radiology (2011) 1.02
Biological impediments to monoclonal antibody-based cancer immunotherapy. Mol Cancer Ther (2004) 1.02
Multiple functions of Na,K-ATPase in epithelial cells. Semin Nephrol (2005) 1.00
HPAF-II, a cell culture model to study pancreatic epithelial cell structure and function. Pancreas (2004) 0.99
Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet Cytogenet (2005) 0.99
Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor. Exp Cell Res (2011) 0.98
Distinct contributions of microtubule subtypes to cell membrane shape and stability. Nanomedicine (2007) 0.98
alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling. Mol Cancer Ther (2008) 0.97
Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. J Urol (2007) 0.97
N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Mol Cancer Ther (2005) 0.94
Identification of candidate tumor oncogenes by integrative molecular analysis of choroidal melanoma fine-needle aspiration biopsy specimens. Arch Ophthalmol (2010) 0.94
Na,K-ATPase beta1-subunit increases the translation efficiency of the alpha1-subunit in MSV-MDCK cells. Mol Biol Cell (2004) 0.93
Disruption of the gene encoding the beta1-subunit of transducin in the Rd4/+ mouse. Invest Ophthalmol Vis Sci (2006) 0.93
Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. Mol Cancer Res (2011) 0.92
Structural characterization, tissue distribution, and functional expression of murine aminoacylase III. Am J Physiol Cell Physiol (2003) 0.91
Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine. Mol Pharm (2012) 0.91
The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression. PLoS One (2013) 0.90
Specificity of aminoacylase III-mediated deacetylation of mercapturic acids. Drug Metab Dispos (2006) 0.89
Protein expression based multimarker analysis of breast cancer samples. BMC Cancer (2011) 0.88
Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit. J Mol Cell Cardiol (2009) 0.85
Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature. Microvasc Res (2006) 0.85
Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix. Int J Oncol (2007) 0.85
High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy. Mol Vis (2007) 0.85
Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate (2003) 0.85
The functions of RPS19 and their relationship to Diamond-Blackfan anemia: a review. Mol Genet Metab (2006) 0.84
Natural killer T cells in advanced melanoma patients treated with tremelimumab. PLoS One (2013) 0.83
Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel. Biochim Biophys Acta (2009) 0.83
Electron tomography reveals polyhedrin binding and existence of both empty and full cytoplasmic polyhedrosis virus particles inside infectious polyhedra. J Virol (2011) 0.83
Isolation of synaptic terminals from Alzheimer's disease cortex. Cytometry A (2011) 0.82
Na,K-ATPase β-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells. J Cell Sci (2012) 0.82
Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin. Cancer Chemother Pharmacol (2009) 0.81
Expression of Na,K-ATPase beta-subunit in transformed MDCK cells increases the translation of the Na,K-ATPase alpha-subunit. Ann N Y Acad Sci (2003) 0.81
Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals. J Clin Immunol (2011) 0.80
Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow. Exp Hematol (2011) 0.80
Novel three-dimensional in vitro models of ovarian endometriosis. J Ovarian Res (2014) 0.80
Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen. Mol Cancer Ther (2006) 0.79
Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. Am J Physiol Lung Cell Mol Physiol (2012) 0.79
International Society for the Advancement of Cytometry cell sorter biosafety standards. Cytometry A (2014) 0.79
Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells. Mol Cancer Ther (2013) 0.79
Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma. Mol Vis (2013) 0.78
Polyribosomes are molecular 3D nanoprinters that orchestrate the assembly of vault particles. ACS Nano (2014) 0.78
Characterization of three cell lines derived from fine needle biopsy of choroidal melanoma with metastatic outcome. Mol Vis (2011) 0.78
Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2. Int J Oncol (2007) 0.78
Pleomorphic malignant fibrous histiocytoma/undifferentiated high-grade pleomorphic sarcoma of the scrotum in a patient presenting as fournier gangrene: a case report. Appl Immunohistochem Mol Morphol (2010) 0.78
Establishment and characterization of a human primary prostate carcinoma cell line, HH870. Prostate (2005) 0.77
Correction: The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression. PLoS One (2013) 0.77
Short communication: enhanced CD8+ T cell apoptosis in HIV-infected adolescents with virologic failure on protease inhibitor-based therapy. AIDS Res Hum Retroviruses (2010) 0.75
Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma. Mol Cancer Ther (2014) 0.75
Coexistence of translocation(1,19) and the Philadelphia chromosome in a child's first presentation of chronic myeloid leukemia in blast crisis treated with dasatinib. Pediatr Hematol Oncol (2011) 0.75
Balancing work and life: an interview with Kathleen Sakamoto. Stem Cells (2009) 0.75
Preface: special issue on critical reviews in leukemogenesis. Crit Rev Oncog (2011) 0.75